The coronavirus illness 2019 (COVID-19) pandemic, brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is threatening folks’s lives and impacting their well being. It’s nonetheless unclear whether or not folks engaged in bodily exercise are at an elevated danger of SARS-CoV-2 an infection and extreme types of COVID-19.
To be able to present knowledge to assist reply this query, we, subsequently, investigated the results of endurance coaching on the degrees of host proteins concerned in SARS-CoV-2 an infection in mice. Eight-week-old C57BL/6J mice have been subjected to treadmill operating (17-25 m/min, 60-90 min, 5 classes/week, eight weeks).
After the intervention, the degrees of angiotensin-converting enzyme 2 (ACE2; host receptor for SARS-CoV-2), transmembrane protease serine 2 (TMPRSS2; host protease priming fusion of SARS-CoV-2 to host cell membranes), FURIN (host protease that promotes binding of SARS-CoV-2 to host receptors), and Neuropilin-1 (host coreceptor for SARS-CoV-2) have been measured in 10 organs that SARS-CoV-2 can infect (larynx, trachea, lung, coronary heart, jejunum, ileum, colon, liver, kidney, and testis).
Six organs (coronary heart, lung, jejunum, liver, trachea, and ileum) confirmed modifications within the ranges of at the very least one of many proteins. Endurance coaching elevated ACE2 ranges in coronary heart (+66.4%), lung (+37.1%), jejunum (+24.7%) and liver (+27.4%), and FURIN in liver (+17.9%) tissue. In distinction, endurance coaching decreased Neuropilin-1 ranges in liver (-39.7%), trachea (-41.2%), and ileum (-39.7%), and TMPRSS2 in lung (-11.3%). Taken collectively, endurance coaching altered the degrees of host proteins concerned in SARS-CoV-2 cell entry in an organ-dependent method.

A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 An infection and Its Software in a Inhabitants-Based mostly Survey by Mail

Noninvasive salivary antibody immunoassays can allow low-cost epidemiological surveillance of infections. This research concerned creating and validating a multiplex suspension immunoassay on the Luminex platform to measure immunoglobulin G (IgG) responses to extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid and spike (S) proteins, and the spike protein’s S1 and S2 subunits and receptor binding area.
A number of variations of those recombinant proteins acquired from industrial and noncommercial sources have been evaluated. Assay growth and validation utilized saliva and serum samples from coronavirus illness 2019 (COVID-19) instances procured from industrial sources and damaging controls from a prepandemic survey.
Saliva was additionally collected in an illustration survey by mail involving grownup people in the US who have been recognized with SARS-CoV-2 an infection 15 to 80 days previous to pattern assortment. The survey had an 83% legitimate pattern return price (192 samples from 38 states).
Most COVID-19 instances (93%) reported mildly symptomatic or asymptomatic infections. The ultimate salivary assay primarily based on the best-performing spike and nucleocapsid proteins had a sensitivity of 87.1% (95% bootstrap confidence interval, 82.1 to 91.7%) and specificity of 98.5% (95.Zero to 100%) utilizing 227 and 285 saliva samples, respectively.
The identical assay had 95.9% (92.eight to 98.9%) sensitivity and 100% (98.Four to 100%) specificity in serum (174 and 285 serum samples, respectively). Salivary and serum antibody responses to spike and nucleocapsid proteins have been strongly correlated in 22 paired samples (r = 0.88 and r = 0.80, respectively). Antibody responses peaked at roughly 50 days postonset; higher sickness severity was related to stronger responses.
This research demonstrated {that a} salivary antibody assay can be utilized in large-scale inhabitants surveys by mail to raised characterize public well being impacts of COVID-19. IMPORTANCE Given the big impacts of the COVID-19 pandemic, creating instruments for inhabitants surveillance of an infection is of paramount significance.
This text describes the event of a multiplex immunoassay on a Luminex platform to measure salivary immunoglobulin G responses to the spike protein, its two subunits and receptor binding area, and the nucleocapsid protein of SARS-CoV-2. The assay validation utilized serum and saliva samples from prepandemic controls and up to date COVID-19 instances.
A survey by mail focusing on current COVID-19 instances throughout the US additionally demonstrated the utility of secure, at-home self-collection of saliva. By incorporating a number of SARS-CoV-2 proteins, this assay might differentiate responses to pure SARS-CoV-2 infections from responses to most vaccines.
Software of this noninvasive immunoassay in COVID-19 surveillance will help present estimates of cumulative incidence charges of symptomatic and asymptomatic infections in varied communities and subpopulations, temporal patterns of antibody responses, and danger components for an infection.

Roborovski hamster (Phodopus roborovskii) pressure SH101 as a systemic an infection mannequin of SARS-CoV-2

Extreme acute respiratory syndrome CoV-2 (SARS-CoV-2) is presently inflicting a worldwide menace with its unusually excessive transmission charges and fast evolution into various strains. In contrast to typical respiratory viruses, SARS-CoV-2 ceaselessly causes systemic an infection by breaking the boundaries of the respiratory methods.
The event of animal fashions recapitulating the medical manifestations of COVID-19 is of utmost significance not just for the event of vaccines and antivirals but additionally for understanding the pathogenesis. Nonetheless, there has not been developed an animal mannequin for systemic an infection of SARS-CoV-2 representing most features of the medical manifestations of COVID-19 with systemic signs.
Right here we report {that a} Roborovski hamster pressure SH101, a laboratory inbred hamster pressure of P. roborovskii, displayed most signs of systemic an infection upon SARS-CoV-2 an infection as within the case of the human counterpart, in contrast to present COVID-19 animal fashions.
Roborovski hamster pressure SH101 post-infection of SARS-CoV-2 represented most medical signs of COVID-19 resembling snuffling, labored respiratory, dyspnea, cough, hunched posture, progressive weight reduction, ruffled fur, and excessive fever following shaking chills.
Histological examinations additionally revealed preliminary right-predominated pneumonia in addition to slight organ damages within the mind and liver, manifesting systemic COVID-19 instances. Contemplating the advantage of a small animal in addition to its medical manifestations of SARS-CoV-2 an infection in human, this hamster mannequin appears to supply a perfect software to research COVID-19.

A mathematical mannequin for the dynamics of SARS-CoV-2 virus utilizing the Caputo-Fabrizio operator

The pandemic of SARS-CoV-2 virus stays a urgent problem with unpredictable traits which unfold worldwide via human interactions. The present research is specializing in the investigation and evaluation of a fractional-order epidemic mannequin that discusses the temporal dynamics of the SARS-CoV-2 virus in a group. It’s well-known that symptomatic and asymptomatic people have a significant impact on the dynamics of the SARS-CoV-2 virus subsequently, we divide the whole inhabitants into inclined, asymptomatic, symptomatic, and recovered teams of the inhabitants.
Additional, we assume that the vaccine confers everlasting immunity as a result of a number of vaccinations have commenced throughout the globe. The brand new fractional-order mannequin for the transmission dynamics of SARS-CoV-2 virus is formulated by way of the Caputo-Fabrizio fractional-order method with the upkeep of dimension in the course of the technique of fractionalization.
The speculation of mounted level will probably be used to point out that the proposed mannequin possesses a novel answer whereas the well-posedness (bounded-ness and positivity) of the fractional-order mannequin options are mentioned.

SARS-Associated Coronavirus Spike Mosaic S (C) Recombinant (SARS Mosaic S (C) )

PT_42025
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

SARS-Associated Coronavirus Spike Mosaic S (M) Recombinant (SARS Mosaic S (M) )

PT_42026
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

SARS-Associated Coronavirus Spike Mosaic S (N) Recombinant (SARS Mosaic S (N) )

PT_42027
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

SARS Ag Spike Mosaic Protein

30-2003 1 mg Ask for price

SARS Ag Spike Mosaic Protein

30-2004 1 mg Ask for price

Recombinant SARS Mosaic S(C) Antigen

VAC-0278 0.5ml
EUR 798.4
Description: Protein

Recombinant SARS Mosaic S(M) Antigen

VAC-0279 0.5ml
EUR 798.4
Description: Protein

SARS Coronavirus Mosaic Recombinant protein

39-110 0.05 mg
EUR 556.8
Description: SARS or severe acute respiratory syndrome is a lethal kind of pneumonia generated by coronavirus. Coronaviruses are a family of viruses that causes a mild respiratory tract infection is a large type of creatures such as humans, pigs, cows, mice, cats etc. up to this day, the origin of the coronavirus is still unknown.

OPPA01464-100UG - SARS Mosaic S(M) Protein

OPPA01464-100UG 100ug
EUR 177

OPPA01465-100UG - SARS Mosaic S(C) Protein

OPPA01465-100UG 100ug
EUR 177

OPPA01466-100UG - SARS Mosaic S(N) Protein

OPPA01466-100UG 100ug
EUR 177

SARS Associated Spike Mosaic S Protein

20-abx260156
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

SARS Associated Spike Mosaic S Protein

abx260156-20g 20 µg
EUR 950

SARS Associated Spike Mosaic S Protein

abx260156-5g 5 µg
EUR 350

Recombinant SARS SARS Mosaic S(C) Protein, Untagged, E.coli-1mg

QP13420-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-1mg

QP13421-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-1mg

QP13422-1mg 1mg
EUR 1273.2

Recombinant SARS SARS Mosaic S(C) Protein, Untagged, E.coli-100ug

QP13420-100ug 100ug
EUR 261.6

Recombinant SARS SARS Mosaic S(C) Protein, Untagged, E.coli-500ug

QP13420-500ug 500ug
EUR 795.6

Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-100ug

QP13421-100ug 100ug
EUR 261.6

Recombinant SARS SARS Mosaic S(M) Protein, Untagged, E.coli-500ug

QP13421-500ug 500ug
EUR 795.6

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-100ug

QP13422-100ug 100ug
EUR 261.6

Recombinant SARS SARS Mosaic S(N) Protein, Untagged, E.coli-500ug

QP13422-500ug 500ug
EUR 795.6

Recombinant SARS Associated Spike Mosaic S

MBS143141-01mg 0.1mg
EUR 330

Recombinant SARS Associated Spike Mosaic S

MBS143141-05mg 0.5mg
EUR 825

Recombinant SARS Associated Spike Mosaic S

MBS143141-1mg 1mg
EUR 1260

Recombinant SARS Associated Spike Mosaic S

MBS143141-5x1mg 5x1mg
EUR 5345

SARS Associated Spike Mosaic S(M) Protein

20-abx260155
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

SARS Associated Spike Mosaic S(M) Protein

abx260155-20g 20 µg
EUR 950

SARS Associated Spike Mosaic S(M) Protein

abx260155-5g 5 µg
EUR 350

SARS Associated Spike Mosaic S(N) Protein

20-abx260157
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

SARS Associated Spike Mosaic S(N) Protein

abx260157-20g 20 µg
EUR 950

SARS Associated Spike Mosaic S(N) Protein

abx260157-5g 5 µg
EUR 350

Recombinant SARS Associated Spike Mosaic S(N)

7-07093 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)

7-07094 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(N)

7-07095 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)

7-07096 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)

7-07097 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S(M)

7-07098 1000µg Ask for price

Recombinant SARS Associated Spike Mosaic S©

7-07099 100µg Ask for price

Recombinant SARS Associated Spike Mosaic S©

7-07100 500µg Ask for price

Recombinant SARS Associated Spike Mosaic S©

7-07101 1000µg Ask for price

SARS Associated Spike Mosaic S(M) (Recombinant)

22060688-1 100 µg
EUR 344.89

SARS Associated Spike Mosaic S(N) (Recombinant)

22060689-1 100 µg
EUR 344.89

SARS Associated Spike Mosaic S(C) (Recombinant)

22060690-1 100 µg
EUR 344.89

Recombinant SARS Associated Spike Mosaic S(M)

MBS143140-01mg 0.1mg
EUR 330

Recombinant SARS Associated Spike Mosaic S(M)

MBS143140-05mg 0.5mg
EUR 825

Recombinant SARS Associated Spike Mosaic S(M)

MBS143140-1mg 1mg
EUR 1260

Recombinant SARS Associated Spike Mosaic S(M)

MBS143140-5x1mg 5x1mg
EUR 5345

Recombinant SARS Associated Spike Mosaic S(N)

MBS143142-01mg 0.1mg
EUR 330

Recombinant SARS Associated Spike Mosaic S(N)

MBS143142-05mg 0.5mg
EUR 825

Recombinant SARS Associated Spike Mosaic S(N)

MBS143142-1mg 1mg
EUR 1260

Recombinant SARS Associated Spike Mosaic S(N)

MBS143142-5x1mg 5x1mg
EUR 5345

Recombinant (E.Coli) SARS Associated Spike Mosaic S

RP-1422 100 ug
EUR 343.2

Recombinant (E.Coli) SARS Associated Spike Mosaic S

RP-1423 100 ug
EUR 343.2

Recombinant (E.Coli) SARS Associated Spike Mosaic S

RP-1424 100 ug
EUR 343.2

Recombinant SARS Spike Mosaic Antigen, His-tagged

VAC-0281 0.5ml
EUR 798.4
Description: Protein

OPSA10811-25UG - SARS SPIKE MOSAIC S(C) Protein

OPSA10811-25UG 25ug
EUR 759

SARS-CoV-2 Mosaic Recombinant protein His Tag

ICOV2MOSAICRHIS50UG each
EUR 648
Description: SARS-CoV-2 Mosaic Recombinant protein His Tag

SARS-CoV-2 Mosaic Recombinant protein His Tag

MBS8430824-INQUIRE INQUIRE Ask for price

OPSA10812-100UL - SARS SPIKE MOSAIC S(C) Protein

OPSA10812-100UL 0.1ml
EUR 739

SARS Coronavirus Spike Mosaic Recombinant protein (Center)

39-122 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS Coronavirus Spike Glycoprotein (S1) Mosaic (E. coli)

REC31842-100 0.1
EUR 415.88
Description: Recombinant protein manufactured in E. coli. Contains amino acids 408-470 and 540-573 of the Spike protein immunodominant region. Immunoreactive with sera from SARS-infected individuals.

SARS Coronavirus Spike Glycoprotein (S1) Mosaic (E. coli)

REC31842-500 0.5
EUR 1560.53
Description: Recombinant protein manufactured in E. coli. Contains amino acids 408-470 and 540-573 of the Spike protein immunodominant region. Immunoreactive with sera from SARS-infected individuals.

Recombinant SARS Spike Mosaic Protein S (N-Terminal)

VAng-Lsx0073-inquire inquire Ask for price
Description: SARS spike mosaic protein S (N-terminal), recombinant protein from E. coli.

SARS-Associated Coronavirus Spike Mosaic S (M) Recombinant

rAP-5473 Inquiry Ask for price

SARS-Associated Coronavirus Spike Mosaic S(C) Recombinant

rAP-5474 Inquiry Ask for price

SARS-Associated Coronavirus Spike Mosaic S (N) Recombinant

rAP-5475 Inquiry Ask for price

SARS Coronavirus Spike Mosaic Recombinant protein (C-terminus)

39-123 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

SARS Coronavirus Spike Mosaic Recombinant protein (N-terminus)

39-124 0.1 mg
EUR 556.8
Description: SARS Coronavirus is an enveloped virus containing three outer structural proteins, namely the membrane (M), envelope (E), and spike (S) proteins. Spike (S)-glycoprotein of the virus interacts with a cellular receptor and mediates membrane fusion to allow viral entry into susceptible target cells. Accordingly, S-protein plays an important role in virus infection cycle and is the primary target of neutralizing antibodies.

Recombinant SARS Spike Mosaic S Protein (aa 408-470, 540-573)

VAng-Lsx0056-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 408-470, 540-573 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

SARS-CoV-2 Spike Mosaic Recombinant protein (Center) Liquid

ICOV2SPIKEMOSAICRC100UG each
EUR 648
Description: SARS-CoV-2 Spike Mosaic Recombinant protein (Center) Liquid

SARS-CoV-2 Spike Mosaic Recombinant protein (Center) Liquid

MBS8430890-INQUIRE INQUIRE Ask for price

SARS-CoV-2 Spike E Mosaic Recombinant protein His Tag

ICOV2SPIKEEMOSAICRHIS50UG each
EUR 648
Description: SARS-CoV-2 Spike E Mosaic Recombinant protein His Tag

SARS-CoV-2 Spike E Mosaic Recombinant protein His Tag

MBS8430887-INQUIRE INQUIRE Ask for price

SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag

ICOV2NTMOSAICRHIS50UG each
EUR 648
Description: SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag

SARS-CoV-2 Nucleocapsid Mosaic Recombinant protein His Tag

MBS8430848-INQUIRE INQUIRE Ask for price

SARS, Spike Protein, Mosaic (CT), Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS635500-1mg 1mg
EUR 1930

SARS, Spike Protein, Mosaic (CT), Recombinant (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS635500-5x1mg 5x1mg
EUR 8540

SARS-CoV-2 (COVID-19) Spike E Mosaic Recombinant protein

39-114 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS-CoV-2 (COVID-19) Nucleocapsid Mosaic Recombinant protein

39-115 0.05 mg
EUR 556.8
Description: A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019. The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2)  in humans. While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

SARS Coronavirus Spike Glycoprotein (S1) Mosaic (N-Term) (E. coli)

REC31840-100 0.1
EUR 415.88
Description: Recombinant protein manufactured in E. coli. Contains the N-terminal section of the Spike protein immunodominant regions (aa 1-53, 90-115, 171-205). Immunoreactive with sera from SARS-infected individuals.

SARS Coronavirus Spike Glycoprotein (S1) Mosaic (N-Term) (E. coli)

REC31840-500 0.5
EUR 1560.53
Description: Recombinant protein manufactured in E. coli. Contains the N-terminal section of the Spike protein immunodominant regions (aa 1-53, 90-115, 171-205). Immunoreactive with sera from SARS-infected individuals.

SARS Coronavirus Spike Glycoprotein (S2) Mosaic (C-Term) (E. coli)

REC31841-100 0.1
EUR 415.88
Description: Recombinant protein manufactured in E. coli. Contains the C-terminal section of the Spike protein immunodominant regions. Immunoreactive with sera from SARS-infected individuals.

SARS Coronavirus Spike Glycoprotein (S2) Mosaic (C-Term) (E. coli)

REC31841-500 0.5
EUR 1560.53
Description: Recombinant protein manufactured in E. coli. Contains the C-terminal section of the Spike protein immunodominant regions. Immunoreactive with sera from SARS-infected individuals.

SARS-CoV-2 Spike-E-M Mosaic Protein, His-tag (E. coli)

REC31829-100 0.1
EUR 427.47
Description: Recombinant protein containing Spike (S), Envelope (E) and Membrane (M) immunodominant regions. Expressed and purified in E. coli with C-terminal His-tag.

SARS-CoV-2 Spike-E-M Mosaic Protein, His-tag (E. coli)

REC31829-500 0.5
EUR 1628.77
Description: Recombinant protein containing Spike (S), Envelope (E) and Membrane (M) immunodominant regions. Expressed and purified in E. coli with C-terminal His-tag.

SARS-CoV-2 Spike Mosaic Recombinant protein (C-terminus) Liquid

ICOV2SPIKEMOSAICRCT100UG each
EUR 648
Description: SARS-CoV-2 Spike Mosaic Recombinant protein (C-terminus) Liquid

SARS-CoV-2 Spike Mosaic Recombinant protein (N-terminus) Liquid

ICOV2SPIKEMOSAICRNT100UG each
EUR 648
Description: SARS-CoV-2 Spike Mosaic Recombinant protein (N-terminus) Liquid

SARS-CoV-2 Spike Mosaic Recombinant protein (C-terminus) Liquid

MBS8430891-INQUIRE INQUIRE Ask for price

SARS-CoV-2 Spike Mosaic Recombinant protein (N-terminus) Liquid

MBS8430892-INQUIRE INQUIRE Ask for price

Recombinant SARS Spike Mosaic S Protein (aa 12-53, 90-115, 171-203)

VAng-Lsx0055-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 12-53, 90-115, 171-203 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

Recombinant SARS Spike Mosaic S Protein (aa 1051-1076, 1121-1154, 1162-1190)

VAng-Lsx0057-inquire inquire Ask for price
Description: Recombinant SARS-CoV Spike protein containing 1051-1076, 1121-1154, 1162-1190 amino acids immunodominant regions was expressed in E. coli and purified by proprietary chromatographic technique.

SARS, Spike Protein, Mosaic (M), Recombinant (aa408-470, 540-573) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS637395-01mg 0.1mg
EUR 490

SARS, Spike Protein, Mosaic (M), Recombinant (aa408-470, 540-573) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS637395-05mg 0.5mg
EUR 1065

SARS, Spike Protein, Mosaic (M), Recombinant (aa408-470, 540-573) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS637395-5x05mg 5x0.5mg
EUR 4635

SARS, Spike Protein, Mosaic (N), Recombinant (aa12-53, 90-115, 171-203) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS636282-01mg 0.1mg
EUR 490

SARS, Spike Protein, Mosaic (N), Recombinant (aa12-53, 90-115, 171-203) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS636282-05mg 0.5mg
EUR 1065

SARS, Spike Protein, Mosaic (N), Recombinant (aa12-53, 90-115, 171-203) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS636282-5x05mg 5x0.5mg
EUR 4635

SARS, Spike Protein, Mosaic (C), Recombinant (aa1051-1076, 1121-1154, 1162-1190) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS636727-01mg 0.1mg
EUR 490

SARS, Spike Protein, Mosaic (C), Recombinant (aa1051-1076, 1121-1154, 1162-1190) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS636727-05mg 0.5mg
EUR 1065

SARS, Spike Protein, Mosaic (C), Recombinant (aa1051-1076, 1121-1154, 1162-1190) (Severe Acute Respiratory Syndrome, SARS-CoV, SARS Associated Coronavirus)

MBS636727-5x05mg 5x0.5mg
EUR 4635

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

00196-V 1 MG
EUR 850

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

00196-V-100ugvial 100 ug/vial
EUR 150
Description: SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

MBS485198-01mg 0.1mg
EUR 300

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

MBS485198-1mg 1mg
EUR 1300

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

MBS485198-5x1mg 5x1mg
EUR 5795

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

00196-V-01 100 µg Ask for price

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573.

00196-V-02 1 mg Ask for price

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

00195-V 1 MG
EUR 850

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

00195-V-100ugvial 100 ug/vial
EUR 150
Description: SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190.

00197-V 1 MG
EUR 850

SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190.

00197-V-100ugvial 100 ug/vial
EUR 150
Description: SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190.

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

MBS485108-01mg 0.1mg
EUR 300

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

MBS485108-1mg 1mg
EUR 1300

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

MBS485108-5x1mg 5x1mg
EUR 5795

SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190.

MBS485135-01mg 0.1mg
EUR 300

SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190.

MBS485135-1mg 1mg
EUR 1300

SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190.

MBS485135-5x1mg 5x1mg
EUR 5795

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

00195-V-01 100 µg Ask for price

SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203.

00195-V-02 1 mg Ask for price

SARS-Associated Coronavirus Spike mosaic recombinant antigen S (C) a.a. 1051-1076/1121-1154/1162-1190.

00197-V-01 100 µg Ask for price

SARS-Associated Coronavirus Spike mosaic recombinant antigen S (C) a.a. 1051-1076/1121-1154/1162-1190.

00197-V-02 1 mg Ask for price

Cytomegalo Virus Mosaic Recombinant (CMV Mosaic)

PT_40269
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

HTLV-1 Mosaic Recombinant (HTLV-1 mosaic)

PT_41086
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Coronavirus, SARS Associated, Nucleocapsid, Mosaic, Recombinant (aa1-49, 192-220) (Severe Acute Respiratory Syndrome)

MBS636445-01mg 0.1mg
EUR 490

Coronavirus, SARS Associated, Nucleocapsid, Mosaic, Recombinant (aa1-49, 192-220) (Severe Acute Respiratory Syndrome)

MBS636445-05mg 0.5mg
EUR 1065

Coronavirus, SARS Associated, Nucleocapsid, Mosaic, Recombinant (aa1-49, 192-220) (Severe Acute Respiratory Syndrome)

MBS636445-5x05mg 5x0.5mg
EUR 4635

Hepatitis E Virus Mosaic Recombinant (HEV Mosaic)

PT_40939
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1 mg

CMV Mosaic

cmv-217 100µg
EUR 165
Description: Recombinant Cytomegalo Virus Mosaic

EBV Mosaic

ebv-275 100µg
EUR 165
Description: Recombinant Epstein-Barr Virus (HHV-4) Mosaic p18

Plasmodium Falciparum Cs Mosaic Recombinant (PfCs Mosaic)

PT_41736
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Rubella Mosaic

rub-291 100µg
EUR 165
Description: Recombinant Rubella Virus E1 Mosaic

Treponema Mosaic

trp-276 100µg
EUR 200
Description: Recombinant Treponema pallidum Mosaic

HTLV-I gp46 Mosaic Recombinant (HTLV-1 gp46 mosaic)

PT_41085
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Treponema pallidum p41 Mosaic Recombinant (T.pallidum p41 Mosaic)

PT_42176
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis C Virus NS4 Mosaic Recombinant (HCV NS4 Mosaic)

PT_40896
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis E Virus Mosaic-S Recombinant (HEV Mosaic-S)

PT_40938
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

HCV Mosaic-A

hcv-001 100µg
EUR 165
Description: Recombinant Hepatitis C Virus Mosaic Antigen-A

HCV Mosaic-B

hcv-002 100µg
EUR 165
Description: Recombinant Hepatitis C Virus Mosaic Antigen-B

HCV NS4 Mosaic

hcv-205 100µg
EUR 165
Description: Recombinant Hepatitis C Virus NS4 Mosaic 

HSV-8 Mosaic

hsv-225 100µg
EUR 165
Description: Recombinant Herpes Simplex Virus-8 Mosaic

Mosaic cytomegalovirus

MBS596105-1mg 1mg
EUR 425

Mosaic cytomegalovirus

MBS596105-2mg 2mg
EUR 700

Mosaic cytomegalovirus

MBS596105-5mg 5mg
EUR 1505

HTLV-1 Mosaic

hiv-144 100µg
EUR 165
Description: Recombinant HTLV-1 Mosaic

EBV EBNA1 Mosaic

ebv-271 100µg
EUR 165
Description: Recombinant Epstein-Barr Virus (HHV-4) EBNA1 Mosaic

EBV EBNA1 Mosaic

PT-A01482
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis C Virus Mosaic Antigen-B Recombinant (HCV Mosaic-B)

PT_73803
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis C Virus Mosaic Antigen-A Recombinant (HCV Mosaic-A)

PT_73804
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

HIV-1 gp120 Nef Mosaic Recombinant (HIV-1 gp120 Nef Mosaic)

PT_40963
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Treponema p41 Mosaic

trp-244 100µg
EUR 165
Description: Recombinant Treponema pallidum p41 Mosaic

Cytomegalo Virus Mosaic

MBS555860-01mg 0.1mg
EUR 340

Cytomegalo Virus Mosaic

MBS555860-05mg 0.5mg
EUR 810

Cytomegalo Virus Mosaic

MBS555860-5x05mg 5x0.5mg
EUR 3495

Cytomegalo Virus Mosaic

PR27123 500 ug
EUR 197.1

Cytomegalo Virus Mosaic

PR27123-B each
EUR 540

TREPONEMA PALLIDUM MOSAIC

GWB-96D8B3 1 mg Ask for price

EBV P18 Mosaic protein

DAG1582 100 µg
EUR 585.38
Description: Recombinant

Mosaic HIV1/2 antigen

MBS596015-1mg 1mg
EUR 340

Mosaic HIV1/2 antigen

MBS596015-2mg 2mg
EUR 505

Mosaic HIV1/2 antigen

MBS596015-5mg 5mg
EUR 1025

HTLV Mosaic protein [GST]

DAG1572 100 µg
EUR 585.38
Description: Recombinant

HTLV-1 Mosaic Protein

20-abx260286
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

HTLV-1 Mosaic Protein

abx260286-25g 25 µg
EUR 950

HTLV-1 Mosaic Protein

abx260286-5g 5 µg
EUR 350

Rubella Virus E1 mosaic

GWB-9E07D0 1 mg Ask for price

Rubella Virus E1 Mosaic

MBS555862-01mg 0.1mg
EUR 340

Rubella Virus E1 Mosaic

MBS555862-05mg 0.5mg
EUR 810

Rubella Virus E1 Mosaic

MBS555862-5x05mg 5x0.5mg
EUR 3495

Rubella Virus E1 Mosaic

PR27125 500 ug
EUR 197.1

Rubella Virus E1 Mosaic

PR27125-B each
EUR 540

CMV gB mosaic 39 kDa

PR-1444-L 1mg
EUR 1480.78
Description: recombinant, E. coli

CMV gB mosaic 39 kDa

PR-1444-S 200µg
EUR 370.29
Description: recombinant, E. coli

Malaria Cs Mosaic Protein

20-abx260295
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 0.5 mg
  • 1 mg

HCV NS4 mosaic 70 kDa

PR-1410-L 1mg
EUR 988.32
Description: recombinant, E. coli

HCV NS4 mosaic 70 kDa

PR-1410-S 200µg
EUR 246.99
Description: recombinant, E. coli

Tp TmpA mosaic 32 kDa

PR-1424-L 1mg
EUR 988.32
Description: recombinant, E. coli

Tp TmpA mosaic 32 kDa

PR-1424-S 200µg
EUR 246.99
Description: recombinant, E. coli

HCV core mosaic 33 kDa

PR-1404-L 1mg
EUR 988.32
Description: recombinant, E. coli

HCV core mosaic 33 kDa

PR-1404-S 200µg
EUR 246.99
Description: recombinant, E. coli

Recombinant HTLV-1 Mosaic

7-07771 100µg Ask for price

Recombinant HTLV-1 Mosaic

7-07772 500µg Ask for price

Recombinant HTLV-1 Mosaic

7-07773 1000µg Ask for price

Recombinant HTLV-1 Mosaic

MBS142628-01mg 0.1mg
EUR 330

Recombinant HTLV-1 Mosaic

MBS142628-05mg 0.5mg
EUR 825

Recombinant HTLV-1 Mosaic

MBS142628-1mg 1mg
EUR 1515

Recombinant HTLV-1 Mosaic

MBS142628-5x1mg 5x1mg
EUR 6485

HTLV-1 Mosaic Recombinant

rAP-5386 Inquiry Ask for price

Hepatitis C Virus NS4 Mosaic Genotype-5 Recombinant (HCV NS4 Mosaic Genotype-5)

PT_40894
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis C Virus NS4 Mosaic Genotype-1 Recombinant (HCV NS4 Mosaic Genotype-1)

PT_40897
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis C Virus NS4 Mosaic Genotype-2 Recombinant (HCV NS4 Mosaic Genotype-2)

PT_40898
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Hepatitis C Virus NS4 Mosaic Genotype-3 Recombinant (HCV NS4 Mosaic Genotype-3)

PT_40899
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 µg
  • 500 µg
  • 1000 µg

Recombinant Malaria Cs Mosaic

7-07090 100µg Ask for price

Recombinant Malaria Cs Mosaic

7-07091 500µg Ask for price

Recombinant Malaria Cs Mosaic

7-07092 1000µg Ask for price

Malaria Cs Mosaic (Recombinant)

22060547-1 100 µg
EUR 344.89
The regular states of the mannequin are analyzed and the sensitivity evaluation of the fundamental reproductive quantity is explored. Furthermore to parameterize the mannequin an actual knowledge of SARS-CoV-2 virus reported within the Sultanate of Oman from January 1st, 2021 to Could 23rd, 2021 are used. We then carry out the massive scale numerical findings to point out the validity of the analytical work.
Cynthia

LEAVE A REPLY

Please enter your comment!
Please enter your name here